ODDB.org: Open Drug Database

Swissmedic Registration	67510	Date of registration	08.01.2020
Company name	Similasan AG	Revision date
		Valid until
Indication		Date of market entry
Index Therapeuticus (BSV)		Revocation Date
Index Therapeuticus (Swissmedic)	20.01.10.	Information for professionals

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Similasan Reise-Beschwerden N	Tabletten	Tablets (Cerium Oxalicum (Hab) D15 6.25 mg, Hyoscyamus Niger D15 6.25 mg, Mandragora E Radice Siccata D15 6.25 mg, Cocculus (Ph.Eur.Hom.) D15 6.25 mg)	A04AZ	CI

2025	©ywesee GmbH